4m. Other investors in the round included Kleiner Perkins, Google Ventures, Roche and Labcorp. In September 2013, J.P. Morgan and Goldman Sachs led the IPO of Foundation Medicine. As of 240, January 2014, Foundation Medicine had a market capitalization of 5900m. 23andme 23andme is the leading direct to consumer genomics13 c